Lapatinib plus capecitabine in metastatic human epidermal growth factor receptor 2-positive breast cancer patients that received prior therapy with trastuzumab and pertuzumab: Better option than T-DM1?

Altundag K.

JOURNAL OF BUON, vol.22, no.1, pp.281-282, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 22 Issue: 1
  • Publication Date: 2017
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.281-282
  • Hacettepe University Affiliated: Yes